Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Smoking Cessation |
| Therapuetic Areas: | Endocrinology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | July 2010 |
| End Date: | November 2013 |
This project will be a randomized clinical trial testing the efficacy of an
internet-administered smoking cessation treatment for overweight and obese smokers. Research
on internet-administered behavioral treatments for smoking cessation has found that compared
to control treatments (e.g., self-help materials), cessation rates in internet-administered
treatments are significantly higher. Research testing the applicability of these treatments
to overweight and obese individuals has not yet been conducted. Given that a substantial
portion of smokers are also overweight and at elevated cardiovascular risk, there is a need
for directed treatment efforts for this group. The current trial proposes to be the first to
test the effectiveness of internet-administered smoking cessation treatment for overweight
and obese (BMI≥25) smokers. Adult participants will be randomized to receive 12 weeks of
internet-administered treatment consisting of either: a) standard smoking cessation
treatment with general health education, or b) standard smoking cessation treatment with
cognitive behavioral therapy (CBT) for weight concerns. Participants in both conditions will
receive open-label treatment with the 21 mg transdermal nicotine patch.
internet-administered smoking cessation treatment for overweight and obese smokers. Research
on internet-administered behavioral treatments for smoking cessation has found that compared
to control treatments (e.g., self-help materials), cessation rates in internet-administered
treatments are significantly higher. Research testing the applicability of these treatments
to overweight and obese individuals has not yet been conducted. Given that a substantial
portion of smokers are also overweight and at elevated cardiovascular risk, there is a need
for directed treatment efforts for this group. The current trial proposes to be the first to
test the effectiveness of internet-administered smoking cessation treatment for overweight
and obese (BMI≥25) smokers. Adult participants will be randomized to receive 12 weeks of
internet-administered treatment consisting of either: a) standard smoking cessation
treatment with general health education, or b) standard smoking cessation treatment with
cognitive behavioral therapy (CBT) for weight concerns. Participants in both conditions will
receive open-label treatment with the 21 mg transdermal nicotine patch.
Inclusion Criteria:
- Smoking 10 or more cigarettes per day
- Regular access to the internet
- BMI>=25
Exclusion Criteria:
- Type I diabetes or Type II diabetes requiring medication
- Alcohol or drug dependence within the past year
- Females with current pregnancy or breastfeeding or intention to become pregnant
within the next 12 months
- Uncontrolled hypertension
- Severe chronic obstructive pulmonary disease
- Use of an investigational drug within 30 days or current participation in another
clinical trial
- Current use of tobacco products other than cigarettes or use of marijuana
- Use of nicotine replacement therapy, clonidine, varenicline, bupropion, or
nortriptyline within the month prior to enrollment
- Use of a medication that might affect weight or appetite
- History of allergic reactions to adhesives.
We found this trial at
1
site
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
Click here to add this to my saved trials
